insights_auto
Why is 4AB down 2,74%?
Dive Deeperchevron_right
4AB:ETR
AbbVie Common Stock
237,90 €
arrow_downward
-2,74%(-6,70) 1D
8-окт., 17:35:49 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
244,30 €
High
244,30 €
Low
237,90 €
Mkt. cap
470,11 млд
Avg. vol.
672,00
Volume
432,00
52-wk high
244,60 €
52-wk low
162,85 €
No. of employees
57 миң
Open
244,30 €
High
244,30 €
Low
237,90 €
Mkt. cap
470,11 млд
Avg. vol.
672,00
Volume
432,00
52-wk high
244,60 €
52-wk low
162,85 €
No. of employees
57 миң
News stories
From web sources and news partners
Simply Wall Street
·
1 саат мурун
AbbVie (ABBV) Lands Two FDA Breakthrough Tags For Temab A In Cancer
Yahoo! Finance Canada
·
1 саат мурун
AbbVie's Temab-A Gets Two FDA Breakthrough Therapy Tags in Cancer
AD HOC NEWS
·
2 саат мурун
Cantor Fitzgerald raises target for AbbVie stock to USD 290.00
Investing.com
·
4 саат мурун
Cantor Fitzgerald raises Abbvie stock price target on drug performance
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57 миң
Founded2012-ж., 10-апр.
HeadquartersСевер Чикаго, Иллинойс, Америка Кошмо Штаттары
Sector-
Websiteabbvie.com